Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain.

NPS club drugs drug abuse drug misuse new psychoactive substances substance-induced psychosis

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 08 08 2024
revised: 19 09 2024
accepted: 15 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

illegal drugs significantly contribute to global health issues, with health complications often occurring not only in regular users with Substance Use Disorders (SUDs) but also in first-time and occasional users. this study examines five clinical cases from a public hospital in Ibiza, Spain, where patients presented with acute psychiatric symptoms due to recreational drug use. Contrary to previous studies on SUDs, our patients typically had higher education levels and stable employment. Most of them used multiple substances, with cannabis, cocaine, and alcohol being the most frequently used. There was also a common occurrence of consuming drugs with uncertain contents. Upon admission, typical symptoms included aggression, hallucinations, mood swings, and disorientation in time and space. Our findings underscore the significant mental health risks posed by illicit drugs, even for individuals with no prior psychiatric history. Factors like the drug's potency, frequency and amount of use, past mental health issues, personality traits, and previous traumatic experiences might influence the onset of these symptoms.

Sections du résumé

BACKGROUND BACKGROUND
illegal drugs significantly contribute to global health issues, with health complications often occurring not only in regular users with Substance Use Disorders (SUDs) but also in first-time and occasional users.
METHODS METHODS
this study examines five clinical cases from a public hospital in Ibiza, Spain, where patients presented with acute psychiatric symptoms due to recreational drug use.
RESULTS RESULTS
Contrary to previous studies on SUDs, our patients typically had higher education levels and stable employment. Most of them used multiple substances, with cannabis, cocaine, and alcohol being the most frequently used. There was also a common occurrence of consuming drugs with uncertain contents. Upon admission, typical symptoms included aggression, hallucinations, mood swings, and disorientation in time and space.
CONCLUSIONS CONCLUSIONS
Our findings underscore the significant mental health risks posed by illicit drugs, even for individuals with no prior psychiatric history. Factors like the drug's potency, frequency and amount of use, past mental health issues, personality traits, and previous traumatic experiences might influence the onset of these symptoms.

Identifiants

pubmed: 39459026
pii: ph17101387
doi: 10.3390/ph17101387
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Chiara Montemitro (C)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Alessio Mosca (A)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Stefania Chiappini (S)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.
School of Medicine, UniCamillus International Medical School University, Via di S. Alessandro 8, 00131 Rome, Italy.

Andrea Miuli (A)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Fabrizio Schifano (F)

Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.

Maria Josè Gordillo Montano (MJG)

Hospital Can Misses Hospital, 07800 Eivissa, Spain.

Cristina Merino Del Villar (CMD)

Hospital Can Misses Hospital, 07800 Eivissa, Spain.

Rita Allegretti (R)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Carlotta Marrangone (C)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Gilberto Di Petta (G)

Mental Health Department, Santa Maria delle Grazie Hospital, ASL 2, 80078 Naples, Italy.

Domenico De Berardis (D)

Department of Mental Health, ASL, 64100 Teramo, Italy.

Mauro Pettorruso (M)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Giovanni Martinotti (G)

Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti, 66100 Chieti, Italy.

Classifications MeSH